Compare AbCellera Biologics Inc (ABCL) vs Nucor Corporation (NUE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Nucor Corporation — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while Nucor Corporation trades at $271.95 (market cap $61.93B). The key difference: Nucor Corporation is far larger — about 20.7× AbCellera Biologics Inc's market cap, and Nucor Corporation pays a 0.82% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | NUE | |
|---|---|---|
Market Cap | $2.99B | $61.93B |
Sector | Health | Basic Materials |
52-Week High | $9.76 | $274.74 |
52-Week Low | $2.78 | $131.78 |
Enterprise Value | $2.58B | $66.34B |
Dividend Yield | — | 0.82% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Nucor Corporation
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →
